ReviewFrontiers in oncology2018

Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC.

Weimin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.